Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer.
Luigi IppolitoAssia DuattiMarta IozzoGiuseppina ComitoElisa PardellaNicla LoritoMarina BacciErica PranziniAlice SantiGiada SandriniCarlo Vittorio CatapanoSergio SerniPietro SpataforaAndrea MorandiElisa GiannoniPaola ChiarugiPublished in: EMBO reports (2024)
Extracellular matrix (ECM) is a major component of the tumor environment, promoting the establishment of a pro-invasive behavior. Such environment is supported by both tumor- and stromal-derived metabolites, particularly lactate. In prostate cancer (PCa), cancer-associated fibroblasts (CAFs) are major contributors of secreted lactate, able to impact on metabolic and transcriptional regulation in cancer cells. Here, we describe a mechanism by which CAF-secreted lactate promotes in PCa cells the expression of genes coding for the collagen family. Lactate-exploiting PCa cells rely on increased α-ketoglutarate (α-KG) which activates the α-KG-dependent collagen prolyl-4-hydroxylase (P4HA1) to support collagen hydroxylation. De novo synthetized collagen plays a signaling role by activating discoidin domain receptor 1 (DDR1), supporting stem-like and invasive features of PCa cells. Inhibition of lactate-induced collagen hydroxylation and DDR1 activation reduces the metastatic colonization of PCa cells. Overall, these results provide a new understanding of the link between collagen remodeling/signaling and the nutrient environment exploited by PCa.
Keyphrases
- prostate cancer
- induced apoptosis
- extracellular matrix
- cell cycle arrest
- squamous cell carcinoma
- small cell lung cancer
- wound healing
- stem cells
- signaling pathway
- gene expression
- tissue engineering
- radical prostatectomy
- cell death
- oxidative stress
- poor prognosis
- bone marrow
- ms ms
- single cell
- binding protein
- anti inflammatory
- diabetic rats
- endothelial cells
- cell therapy